Balanced news tone
News Sentiment
SVNS sentiment intelligence
Solvonis Therapeutics plc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
53
Balanced news tone
11 relevant articles
News tone and price action are not far from neutral.
95/100 classification confidence.
directly relevant articles
high-authority source matches
-3.6% over one week, -21.0% over four weeks, trend inactive, and below fair value.
Why Solvonis Therapeutics (LSE:SVNS) Is Drawing Fresh Attention
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
95/100 classification
One-week reaction
-3.6%
Price reacting lower
Trend fit
Trend inactive
-21.0% over four weeks
Fair value
-67.1%
Below fair value
Value support
Sentiment Mix
Positive, neutral, negative
Positive
2
Neutral
9
Negative
0
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
Kalkine Media
Direct company coverage
Why Solvonis Therapeutics (LSE:SVNS) Is Drawing Fresh Attention
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Jul 2026 11:07
- Source
- Kalkine Media
Yahoo! Finance Canada
Direct company coverage
US Research house initiates Solvonis coverage citing differentiated addiction strategy
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Jul 2026 09:10
- Source
- Yahoo! Finance Canada
Kalkine Media
Direct company coverage
Solvonis Therapeutics Gains (LSE:SVNS) US Spotlight as Clinical Pipeline Advances
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 13 Jul 2026 08:24
- Source
- Kalkine Media
Proactive Investors
Direct company coverage
Solvonis shares up 12% after clears key hurdle in bid to treat alcohol addiction with esketamine treatment - UPDATE
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 Jun 2026 07:00
- Source
- Proactive Investors
Market source
Direct company coverage
Solvonis Therapeutics refines strategy around SVN-001 phase III value inflexion point
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 Apr 2026 07:00
- Source
- Market source
Proactive Investors
Direct company coverage
Sunda Energy, Union Jack Oil, Solvonis, Coiled Therapeutics, Frontier IP, Quantum Blockchain
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Apr 2026 07:00
- Source
- Proactive Investors
Proactive financial news
Direct company coverage
Solvonis raises £1 million from top investors to accelerate AI drug discovery
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 11 Jul 2025 07:00
- Source
- Proactive financial news
TMX Newsfile
Direct company coverage
Awakn Life Sciences Announces Completion of Arrangement and Sale to Solvonis Therapeutics plc
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 May 2025 07:00
- Source
- TMX Newsfile
Proactive financial news
Direct company coverage
Solvonis Therapeutics PLC Share Price - SVNS, RNS News, Articles, Quotes, & Charts (LON:SVNS)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 20 Jan 2025 07:31
- Source
- Proactive financial news
TradingView
Direct company coverage
SVNS Stock Price and Chart — LSE:SVNS
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jan 2025 13:19
- Source
- TradingView
London South East
Direct company coverage
Solvonis Therap Live Share Prices and Trades. SVNS Live Streaming Share Prices.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jan 2025 11:05
- Source
- London South East